Early data from robust Autonomy Phase 2b posdinemab trial demonstrate Company's leadership in multimodal biomarkers and early detection
New findings highlight the central role of...
NEW YORK, July 23, 2025 /PRNewswire/ -- SiriusXM (NASDAQ: SIRI) today announced that its Board of Directors declared a quarterly cash dividend of $0.27...
FAYETTEVILLE, N.C., July 23, 2025 /PRNewswire/ -- MatchAwards has announced the launch of the MAPU Affiliate Program, offering participants the opportunity to earn 20%...
Beauty meets intelligent tech: L'Oréal Turkey unlocks faster, more consistent creative production with AdCreative.ai
ISTANBUL and PARIS, July 23, 2025 /PRNewswire/ -- L'Oréal Turkey has partnered with...
SHORT HILLS, N.J. , July 22, 2025 /PRNewswire/ -- Doceree, the world's first global network for programmatic HCP engagement, has announced the launch of co-pay.com—the...
STOCKHOLM, July 22, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present the latest findings on lecanemab (Leqembi®), including...